Shah Smital bought LYEL
March 9, 2026 · Form 4 insider transaction
Shah Smital bought 140,000 shares of Lyell Immunopharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 7 days after the transaction.
Direction
Acquired (buy-side)
Shares
140,000
Price
$0.00
Total value
N/A
InsiderShah Smital
RoleOfficer
SecurityOption (right to buy)
Transaction codeA: Grant or award
Transaction dateMarch 9, 2026
Filing dateMarch 16, 2026
Shares owned after140,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the option shares will vest on March 9, 2027, with the remaining option shares to vest in equal monthly installments over the following 36 months, subject to the reporting person providing service through the applicable vesting date.